Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
-12.11%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$3.97B
AUM Growth
-$900M
(-18%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
969
New
42
Increased
273
Reduced
549
Closed
52
Top Buys
| 1 |
McDonald's
MCD
|
$20.9M |
| 2 |
Johnson & Johnson
JNJ
|
$14M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$12.7M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$11M |
| 5 |
MSCI
MSCI
|
$10.7M |
Top Sells
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$32.8M |
| 2 |
Home Depot
HD
|
$21.5M |
| 3 |
JPMorgan Chase
JPM
|
$9.67M |
| 4 |
AET
Aetna Inc
AET
|
$9.02M |
| 5 |
Nike
NKE
|
$8.82M |
Sector Composition
| 1 | Technology | 16.16% |
| 2 | Healthcare | 14.34% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Solid Biosciences
SLDB
$428M
| $137K | ﹤0.01% |
321
-73
| -19% | -$31.2K |
|
|
NXRT
802
NexPoint Residential Trust
NXRT
$879M
| $135K | ﹤0.01% |
3,885
+600
| +18% | +$20.8K |
|
803
Accuray
ARAY
$170M
| $134K | ﹤0.01% |
40,362
+17,964
| +80% | +$59.6K |
|
804
The Greenbrier Companies
GBX
$1.46B
| $134K | ﹤0.01% |
3,442
-324
| -9% | -$12.6K |
|
|
NRE
805
DELISTED
NorthStar Realty Europe Corp.
NRE
| $134K | ﹤0.01% |
9,127
| – | – |
|
|
UHT
806
Universal Health Realty Income Trust
UHT
$574M
| $134K | ﹤0.01% |
2,231
| – | – |
|
807
CACI
CACI
$10.4B
| $133K | ﹤0.01% |
946
-17
| -2% | -$2.39K |
|
|
ASXC
808
DELISTED
Asensus Surgical, Inc.
ASXC
| $133K | ﹤0.01% |
4,466
+146
| +3% | +$4.35K |
|
809
Sarepta Therapeutics
SRPT
$1.96B
| $130K | ﹤0.01% |
1,219
-264
| -18% | -$28.2K |
|
810
Xencor
XNCR
$610M
| $130K | ﹤0.01% |
3,722
-254
| -6% | -$8.87K |
|
|
FSP
811
Franklin Street Properties
FSP
$174M
| $129K | ﹤0.01% |
20,396
+3,700
| +22% | +$23.4K |
|
|
MAXR
812
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $127K | ﹤0.01% |
11,196
+7,948
| +245% | +$90.2K |
|
|
NITE
813
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $127K | ﹤0.01% |
+10,417
| New | +$127K |
|
|
RTL
814
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $126K | ﹤0.01% |
+9,370
| New | +$126K |
|
|
MDCO
815
DELISTED
Medicines Co
MDCO
| $125K | ﹤0.01% |
6,990
+2,651
| +61% | +$47.4K |
|
816
ProQR Therapeutics
PRQR
$258M
| $124K | ﹤0.01% |
+6,971
| New | +$124K |
|
817
Inovio Pharmaceuticals
INO
$148M
| $123K | ﹤0.01% |
2,403
+186
| +8% | +$9.52K |
|
818
AeroVironment
AVAV
$11.3B
| $122K | ﹤0.01% |
+1,819
| New | +$122K |
|
819
Abeona Therapeutics
ABEO
$353M
| $121K | ﹤0.01% |
729
+467
| +178% | +$77.5K |
|
820
ESCO Technologies
ESE
$5.23B
| $120K | ﹤0.01% |
1,882
+75
| +4% | +$4.78K |
|
821
uniQure
QURE
$985M
| $120K | ﹤0.01% |
4,397
-52
| -1% | -$1.42K |
|
822
Smith & Nephew
SNN
$16.5B
| $120K | ﹤0.01% |
3,373
+819
| +32% | +$29.1K |
|
823
Vuzix
VUZI
$188M
| $120K | ﹤0.01% |
+23,782
| New | +$120K |
|
824
Qiagen
QGEN
$10.3B
| $119K | ﹤0.01% |
3,327
+920
| +38% | +$32.9K |
|
|
ESL
825
DELISTED
Esterline Technologies
ESL
| $119K | ﹤0.01% |
+993
| New | +$119K |
|